Approximately 95 percent of cancer mortality is caused by metastasis. This fact is what motivates many cancer researchers to focus on finding new ways to stop or kill the growth of metastatic cancer cells. A new paper published ...
Jul 6, 2016
0
44
PI3K (phosphoinositide 3-kinase) is a cell-signaling molecule that has now been implicated in a large number of women's cancers including breast, ovarian and endometrial cancers.
Jan 28, 2016
1
5
Endometriosis - tissue usually found inside the uterus that grows outside - thrives because of altered cellular signaling that is mediated by estrogen, said researchers from Baylor College of Medicine in a report that appears ...
Nov 5, 2015
0
21
Researchers at Uppsala University have, together with researchers from Turku and Bergen, discovered a new biomarker which makes it possible to identify women with uterine cancer who have a high risk of recurrence. The findings ...
Apr 14, 2015
0
4
The Australian first Women's Health, Creating Change trial will focus on women's reproductive cancers, such as ovarian, breast and endometrial cancer.
Nov 19, 2014
0
0
A leukemia drug called dasatinib shows promise for treating skin, breast and several other cancers, according to researchers at Loyola University Chicago Stritch School of Medicine.
Aug 19, 2014
0
0
Progesterone, a female hormone that can be used as a therapy for endometrial cancer, eliminates tumor cells indirectly by binding to its receptor in stromal or connective tissue cells residing in the tumor microenvironment, ...
Jun 11, 2013
0
0
The most in-depth look yet at endometrial cancer shows that adding genomics-based testing to the standard diagnostic workup could change the recommended course of treatment for some women.
May 1, 2013
0
0
Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered a molecule that inhibits the action of estrogen. This female hormone plays a key role in the growth, maintenance and repair of reproductive ...
May 9, 2012
0
0
